Abstract
Introduction
adapter sequences were introduced at both ends of 2 nd round PCR products in 3rd round of sequences were annotated using IMGT . Further data analysis and 150 preparation was done using in house developed sequence analysis pipeline -Immune
151
Receptor Information System (IRIS). Only sequences having number of dupcounts ≥5 was 152 included for the data preparation. In cases, where, for a cell, sequences more than one VH:VL 153 pair appeared, the VH/VL sequence with dupcount ≥5 fold higher than others was selected for 154 analysis, otherwise, the corresponding well was assumed to have more than one cell and 155 discarded from the analysis. If a well contained both IGKV and IGLV sequences then the 156 corresponding cell was assumed to express both chains. Highly similar (<5 nucleotide
Generation of lineage trees

175
Lineage trees for different clonal groups were generated using Alakazam tool (17) after 176 assigning a full length IMGT-numbered, germline sequence to each clone using IMGT Hamming distance of zero from their inferred parent. Branch lengths were assigned as the
182
Hamming distance between sequences; i.e. the number of unambiguous mutation events. 
Results
209
Paired analysis of TG2-specific VH and VL repertoire from single cells specific and 1421 non-TG2-specific PCs were analyzed (Table II) . Consistent with earlier 224 findings (7), TG2-specific PC populations contained many clonally related sequences and
225
showed less heterogeneity than non-TG2-specific PCs, indicating a restricted repertoire 226 (Table II) .
228
Certain L chain V gene segments are overrepresented among TG2-specific PCs
229
Similar to biases observed in BCR V gene usage in several autoimmune conditions (23, 24),
230
VH gene usage among TG2-specific PCs from CD patients were previously found to show a 231 strong bias towards a few IGHV gene segments (6, 7). In the current study, the analysis was 232 extended to TG2-specific VL sequences. Usage frequency was calculated by taking only unique clonotypes into account to exclude the effect of clonal expansion. In a variety of 234 autoantibodies, including rheumatoid factor and antibodies with specificity for dsDNA,
235
phospholipids, histone A2 and laminin,  L chain was more frequent than  L chain (23-26).
236
In contrast, TG2-specific PCs expressed  at higher percentages than non-TG2-specific PCs
237
( Fig. 1A, 1B) . In a previous study, done with a small number of sequences, only 5% of TG2-
238
specific PCs were estimated to use  light chains (6), whereas here, 20% of them were - featuring  L chain were found exclusively among TG2-specific PCs (Fig. 2C ).
275
Analysis of BCR-repertoire similarity using Morisita-Horn indices demonstrated that TG2-276 specific VH:VL sequences from different CD patients clustered closely together and had more 277 relatedness than non-TG2-specific VH:VL sequences (Supplemental Fig. 2 clonal expansion among TG2-specific PCs (Fig. 3A) . Large fractions of the TG2-specific 290 clones were found to be expanded, whereas this was not seen for non-TG2-specific clones
291
( Fig. 3B ). Clonal families with 3 or more cells were also detected at noticeably high levels 292 among TG2-specific PCs (Fig. 3C ), indicative of a restricted repertoire. Certain VH:VL pairs 293 from TG2-specific PCs showed a tendency to expand, and most of them contained IGKV1-39
294
L chains (Fig. 3D) . Among all the clonally expanded TG2-specific VH:VL pairs, the IGHV5-295 51:IGKV1-5 pair was present in most patients (Fig. 3E, 3F ). Though this VH:VL pair could 296 also be detected among the non-TG2-specific PC population in 3 out of 10 patients, these 297 cells did not show any expansion (Fig. 3F ). The VH:VL pair associated with most expanded 298 clones differed patient to patient (Fig. 3G) specific PCs (Fig. 3D, 3F ). This might reflect the observation that IGKV3-20 is among the 306 mostly used VL gene segments in humans (29).
TG2-specific VH and VL carry few mutations
308
We next analyzed the phylogenetic relationship between cells belonging to individual 309 clonotypes and the extent of mutation among TG2-specific VH and VL sequences.
310
Phylogenetic analysis demonstrated that clones with a particular mutation expanded more 311 than others (Fig. 4) , indicating that certain introduced mutations have increased the affinity 312 for TG2. Interestingly, though most of the clones were mutated, a number of them had low 313 mutation levels and a few had only acquired a single mutation (Fig. 4) . Interestingly, we 314 observed that mutation levels in the TG2-specific IGHV and IGKV/IGLV gene segments were 315 significantly lower than those of non-TG2-specific PCs, and the decrease in number of 316 mutations in H and L chains was proportionate ( Fig. 5A , 5B when it was paired with other IGHV gene segments or when it was used by non-TG2-specific
344
PCs, and the frequency of the Q106H substitution was significantly higher than that in TG2- chain when TG2-specific PCs were compared to non-TG2 specific PCs (Fig. 7A ). This 356 peculiar distribution skewing was rooted in the bias for IGHV5-51 and IGKV1-5 among TG2-specific PCs (Fig. 7B, 7C Thus, the autoantibody response in CD appears strongly stereotypic, although some individual 373 variation is also seen.
374
The basis for this study is the observation that single TG2-specific IgA-and IgM-expressing
375
PCs can be isolated with TG2-antigen as bait by taking advantage of the expression of surface
376
Ig by PCs (1, 2). Expression-cloning and testing of mAbs from 63 single PCs, revealed a 377 specificity of 90% in the selection of TG2-specific PCs (6). This high selection efficiency is 378 an important prerequisite for the analysis undertaken in the present study.
379
Technological advances now allow paired sequencing of Ig VH and VL genes from large 380 populations of single B cells (3, 11, 28, 31, 32 sequence data combined for all patients (n=10). TG2+, TG2-specific; TG2-, non-TG2-specific.
583
Significance was determined using a two-tailed t test. n.s., not significant, *p < 0.05, ***p < 584 0.001. 
620
Horizontal bars (A, C and D) show the average value. Number of sequences (from 10 621 patients) is denoted by 'n'. Significance was determined using unpaired t test. ****p < 0.0001. 27-38, 56-65 and 105 correspond to CDR1, CDR2 and the first residue of CDR3, respectively.
632
Underlined AA residues correspond to ones that were predicted to be engaged in binding confidence interval is given in parenthesis. Significance was determined using one-way 644 ANOVA. n.s., not significant, ***p < 0.001, ****p < 0.0001. ID  TG2-TG2+  TG2-TG2+  TG2-TG2+ FIGURE S1. Binding properties of lambda-containing anti-TG2 mAbs in ELISA. 
